A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2015
At a glance
- Drugs Meloxicam (Primary) ; Meloxicam
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Iroko Pharmaceuticals
- 09 Jul 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 19 Apr 2015 Status changed from recruiting to not yet recruiting as per ClinicalTrials.gov record.
- 07 Apr 2015 New trial record